Login
← Go Back
Rubicon Research
RUBICON · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 16, 2025
Stock Price vs Company Growth
1d
3.9%
1w
6.2%
1m
17.3%
3m
6.4%
6m
53.5%
1y
136.9%
all
125.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,431 3.9%
1,413
1,896
Company Overview
Sales
1,936 Cr
Growth: 35.0%
Profit after Tax
288 Cr
Growth: 16.8%
Mid Cap
23,692 Cr
P/E: 81.6x
Industry P/E: 32.9x
Fundamentals
Sales (Cr) ₹ 1,936
Growth 35.0%
EBITDA 23.3%
P/S 12.3x
Dividend 0.0%
P/E 81.6x
Book Value ₹ 83
PEG Ratio 2.4x
ROE 28.7%
P/B 17.9x
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
Rubicon Research, incorporated in 1999, is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. Further, the company has robust sales and distribution capabilities in the US.
Belongs to (22 Indices) view more